Biliary Cholangitis
📧 Sign up to get email alerts when something new happens for Biliary Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness [Phase 2]
The Phase 2 trial of Setanaxib in patients with primary biliary cholangitis has been completed, with results posted on 2025-04-24.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid
This completed clinical trial evaluates how well scoring systems perform in Chinese patients with primary biliary cholangitis who are treate…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) [Phase 1]
An open-label Phase 1 study evaluating oral dosing of seladelpar in adults with primary biliary cholangitis and hepatic impairment (compensa…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC) [Phase 2]
A Phase 2 study evaluating two doses of seladelpar (MBX-8025) for primary biliary cholangitis was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
A real-world data study evaluating the effectiveness of obeticholic acid (Ocaliva) on hepatic outcomes in patients with primary biliary chol…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions [NA]
The document reports completion of a clinical trial evaluating an online mental wellness program for adults across multiple chronic conditio…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis [Phase 3]
A Phase 3 trial comparing obeticholic acid versus placebo in combination with ursodeoxycholic acid for primary biliary cirrhosis has complet…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis [Phase 2]
A Phase 2 clinical trial evaluating ASC42 tablets for safety and efficacy in primary biliary cholangitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis [Phase 2]
This clinical trial update reports on the Phase 2 study evaluating safety, tolerability, and efficacy of saroglitazar magnesium in patients …
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) [Phase 3]
Ipsen announced Phase 3 results for elafibranor in patients with primary biliary cholangitis; the study is listed as ACTIVE_NOT_RECRUITING w…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Early Identification of Myocardial Impairment in PBC
Clinical trial update on early identification of myocardial impairment in Primary Biliary Cholangitis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) [Phase 3]
Phase 3 trial of seladelpar in primary biliary cholangitis has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of obeticholic acid for primary biliary cholangitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating umbilical cord–derived mesenchymal stem cell transplantation in children with biliary atresia; the study…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis [Phase 2]
An open-label Phase 2 study of HTD1801 in adults with primary biliary cholangitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule [Phase 4]
Clinical trial update for a Phase 4 study evaluating Baobao Dan Capsule for elevated total bilirubin in Primary Biliary Cholangitis.
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Combination Antiretroviral Therapy (cART) for PBC [Phase 2]
Phase 2 clinical trial update on combination antiretroviral therapy for Primary Biliary Cholangitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis [Phase 4]
Phase 4 trial of obeticholic acid in primary biliary cholangitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment [Phase 4]
A Phase 4 clinical trial studying the pharmacokinetics and safety of obeticholic acid in participants with primary biliary cholangitis and h…
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) [Phase 2]
Phase 2 clinical trial update for seladelpar (MBX-8025) in subjects with primary biliary cholangitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) [Phase 3]
Phase 3 trial ENHANCE evaluating seladelpar in patients with primary biliary cholangitis who had inadequate response to or intolerance of UD…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy [Phase 3]
Phase 3 clinical trial evaluating 24 months of bezafibrate for primary sclerosing cholangitis with persistent cholestasis despite ursodeoxyc…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis [Phase 2]
Phase 2 trial of etrasimod (APD334) for primary biliary cholangitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy [Phase 4]
Phase 4 trial comparing mycophenolate mofetil to cyclosporin A for treatment of autoimmune hepatitis-primary biliary cholangitis overlap syn…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis [Phase 2]
Phase 2 study evaluating safety, tolerability, pharmacokinetics, and efficacy of EDP-305 in subjects with primary biliary cholangitis has co…